New ECMO device tested for safe transport of critically ill patients

NCT ID NCT07156669

Not yet recruiting Disease control Sponsor: Xenios AG Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new medical device kit (Novalung ultimate kit with Xenios 2.0) in 20 adult patients with severe heart-lung failure who need ECMO life support. The goal is to see if the device safely and effectively maintains blood oxygen levels during hospital use and ground transport. The study is observational, meaning no new treatments are given—just careful monitoring of the device's performance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute lung injury respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE LUNG INJURY CARDIO-RESPIRATORY FAILURE EXTRACORPOREAL MEMBRANE OXYGENATION COMPLICATION

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

Krankenhaus Bethanien gGmbH

Solingen, 42699, Germany

Contact Email: •••••@•••••
University Hospital Aachen

Aachen, 52074, Germany

Contact Email: •••••@•••••